{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T05:19:11Z","timestamp":1791523151038,"version":"4.3.4"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T00:00:00Z","timestamp":1627257600000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Systemic sclerosis (SSc) is a generalized disease of the connective tissue, arterioles, and microvessels, characterized by the appearance of fibrosis and vascular obliteration. There are two main phenotypical forms of SSc: a diffuse cutaneous form that extends towards the proximal region of the limbs and\/or torso, and a limited cutaneous form where the cutaneous sclerosis only affects the extremities of the limbs (without passing beyond the elbows and knees). There also exists in less than 10% of cases forms that never involve the skin. This is called SSc sine scleroderma. The prognosis depends essentially on the occurrence of visceral damage and more particularly interstitial lung disease (which is sometimes severe), pulmonary arterial hypertension, or primary cardiac damage, which represent the three commonest causes of mortality in SSc. Another type of involvement with poor prognosis, scleroderma renal crisis, is rare (less than 5% of cases). Cutaneous extension is also an important parameter, with the diffuse cutaneous forms having less favorable prognosis.<\/jats:p>","DOI":"10.1186\/s13023-021-01844-y","type":"journal-article","created":{"date-parts":[[2021,7,25]],"date-time":"2021-07-25T20:02:23Z","timestamp":1627243343000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["French recommendations for the management of systemic sclerosis"],"prefix":"10.1186","volume":"16","author":[{"given":"Eric","family":"Hachulla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Agard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick","family":"Allanore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Avouac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Bader-Meunier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Belot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Berezne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Bouthors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraldine","family":"Condette-Wojtasik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00ebl","family":"Constans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"De Groote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Diot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Dumas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Jego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisca","family":"Joly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Launay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronique","family":"Le Guern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine-Sophie","family":"Le Quintrec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraldine","family":"Lescaille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Meune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Moulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Omeish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Pene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Aleth","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Rochefort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Roren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Sitbon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Sobanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Elise","family":"Truchetet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Mouthon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Collaborators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Bayen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Bergot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Berthier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Bosco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoram","family":"Bouhnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Chaigne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Cottin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Crestani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Deligny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vianney","family":"Descroix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Farge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Godard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Granel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Guilpain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Imbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Le Quellec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Lega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Lok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Maillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e9gory","family":"Pugnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviane","family":"Queyrel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lo\u00efc","family":"Raffray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Rilliard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Romier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Schuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"Servettaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,26]]},"reference":[{"issue":"8","key":"1844_CR1","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1002\/acr.20480","volume":"63","author":"A Alantar","year":"2011","unstructured":"Alantar A, Cabane J, Hachulla E, Princ G, Ginisty D, Hassin M, et al. Recommendations for the care of oral involvement in patients with systemic sclerosis. Arthritis Care Res (Hoboken). 2011;63(8):1126\u201333.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2 Suppl 81","key":"1844_CR2","first-page":"165","volume":"32","author":"J Avouac","year":"2014","unstructured":"Avouac J, Allanore Y. Targeted immunotherapies in systemic sclerosis. Clin Exp Rheumatol. 2014;32(2 Suppl 81):165\u201372.","journal-title":"Clin Exp Rheumatol"},{"issue":"8","key":"1844_CR3","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1093\/rheumatology\/kes041","volume":"51","author":"J Aouac","year":"2012","unstructured":"Aouac J, Clements PJ, Khanna D, Furst DE, Allanore Y. Articular involvement in systemic sclerosis. Rheumatology (Oxford). 2012;51(8):1347\u201356.","journal-title":"Rheumatology (Oxford)"},{"key":"1844_CR4","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.humpath.2008.08.001","volume":"40","author":"I Batal","year":"2009","unstructured":"Batal I, Domsic RT, Shafer A, Medsger TA, Kiss LP, Randhawa P, Bastacky S. Renal biopsy findings predicting outcome in scleroderma renal crisis. Hum Pathol. 2009;40:332\u201340.","journal-title":"Hum Pathol"},{"issue":"2","key":"1844_CR5","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2340\/00015555-2206","volume":"96","author":"J Baumgartner-Nielsen","year":"2016","unstructured":"Baumgartner-Nielsen J, Olesen AB. Treatment of skin calcifications with intra-lesional injection of sodium thiosulphate: a case series. Acta Derm Venereol. 2016;96(2):257\u20138.","journal-title":"Acta Derm Venereol"},{"issue":"8","key":"1844_CR6","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1002\/art.40123","volume":"69","author":"RJ Bello","year":"2017","unstructured":"Bello RJ, Cooney CM, Melamed E, Follmar K, Yenokyan G, Leatherman G, et al. The therapeutic efficacy of botulinum toxin in treating scleroderma-associated Raynaud\u2019s phenomenon: a randomized, double-blind, placebo-controlled clinical trial. Arthritis Rheumatol Hoboken NJ. 2017;69(8):1661\u20139.","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"issue":"5","key":"1844_CR7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s11926-016-0576-x","volume":"18","author":"RA Berard","year":"2016","unstructured":"Berard RA, Laxer RM. Pediatric mixed connective tissue disease. Curr Rheumatol Rep. 2016;18(5):28.","journal-title":"Curr Rheumatol Rep"},{"key":"1844_CR8","first-page":"1064","volume":"35","author":"A B\u00e9rezn\u00e9","year":"2008","unstructured":"B\u00e9rezn\u00e9 A, Ranque B, Valeyre D, Brauner M, Allanore Y, Launay D, et al. Therapeutic strategy combining intravenous cyclophosphamide followed by oral azathioprine to treat worsening interstitial lung disease associated with systemic sclerosis: a retrospective multicenter open-label study. J Rheumatol. 2008;35:1064\u201372.","journal-title":"J Rheumatol"},{"issue":"6","key":"1844_CR9","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1093\/rheumatology\/kew488","volume":"56","author":"L-A Bissell","year":"2017","unstructured":"Bissell L-A, Anderson M, Burgess M, Chakravarty K, Coghlan G, Dumitru RB, et al. Consensus best practice pathway of the UK Systemic Sclerosis Study group: management of cardiac disease in systemic sclerosis. Rheumatology (Oxford). 2017;56(6):912\u201321.","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"1844_CR10","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1007\/s10067-009-1216-x","volume":"28","author":"SM Bongi","year":"2009","unstructured":"Bongi SM, Del Rosso A, Galluccio F, Sigismondi F, Miniati I, Conforti ML, et al. Efficacy of connective tissue massage and Mc Mennell joint manipulation in the rehabilitative treatment of the hands in systemic sclerosis. Clin Rheumatol. 2009;28(10):1167\u201373.","journal-title":"Clin Rheumatol"},{"issue":"8","key":"1844_CR11","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1002\/acr.20487","volume":"63","author":"SM Bongi","year":"2011","unstructured":"Bongi SM, Del Rosso A, Passalacqua M, Miccio S, Cerinic MM. Manual lymph drainage improving upper extremity edema and hand function in patients with systemic sclerosis in edematous phase. Arthritis Care Res (Hoboken). 2011;63(8):1134\u201341.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"1844_CR12","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.semarthrit.2014.12.001","volume":"44","author":"N Bose","year":"2015","unstructured":"Bose N, Chiesa-Vottero A, Chatterjee S. Scleroderma renal crisis. Semin Arthritis Rheum. 2015;44(6):687\u201394.","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"1844_CR13","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1080\/1744666X.2017.1263153","volume":"13","author":"C Bruni","year":"2017","unstructured":"Bruni C, Praino E, Allanore Y, Distler O, Gabrielli A, Iannone F, et al. Use of biologics and other novel therapies for the treatment of systemic sclerosis. Expert Rev Clin Immunol. 2017;13(5):469\u201382.","journal-title":"Expert Rev Clin Immunol"},{"issue":"6","key":"1844_CR14","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1002\/art.40809","volume":"71","author":"EA Butler","year":"2019","unstructured":"Butler EA, Baron M, Fogo AB, Frech T, Ghossein C, Hachulla E, et al. Scleroderma Clinical Trials Consortium Scleroderma Renal Crisis Working Group. Generation of a core set of items to develop classification criteria for scleroderma renal crisis using consensus methodology. Arthritis Rheumatol. 2019;71(6):964\u201371.","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"1844_CR15","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1002\/art.39311","volume":"67","author":"JS Chen","year":"2015","unstructured":"Chen JS, Roberts CL, Simpson JM, March LM. Pregnancy outcomes in women with rare autoimmune diseases. Arthritis Rheumatol (Hoboken, NJ). 2015;67(12):3314\u201323.","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"issue":"11","key":"1844_CR16","first-page":"1892","volume":"20","author":"PJ Clements","year":"1993","unstructured":"Clements PJ, Lachenbruch PA, Seibold JR, Zee B, Steen VD, Brennan P, et al. Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol. 1993;20(11):1892\u20136.","journal-title":"J Rheumatol"},{"issue":"8","key":"1844_CR17","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.revmed.2017.04.005","volume":"38","author":"V Coirier","year":"2017","unstructured":"Coirier V, Lescoat A, Fournet M, Cazalets C, Coiffier G, Jouneau S, et al. Screening for pulmonary arterial hypertension in patients with systemic sclerosis: comparison of DETECT algorithm to decisions of a multidisciplinary team, in a competence centre. Rev Med Interne. 2017;38(8):502\u20137.","journal-title":"Rev Med Interne"},{"issue":"9","key":"1844_CR18","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1093\/rheumatology\/40.9.1038","volume":"40","author":"B Coleiro","year":"2001","unstructured":"Coleiro B, Marshall SE, Denton CP, Howell K, Blann A, Welsh KI, et al. Treatment of Raynaud\u2019s phenomenon with the selective serotonin reuptake inhibitor fluoxetine. Rheumatol Oxf Engl. 2001;40(9):1038\u201343.","journal-title":"Rheumatol Oxf Engl"},{"issue":"132","key":"1844_CR19","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1183\/09059180.00001814","volume":"23","author":"V Cottin","year":"2014","unstructured":"Cottin V, Crestani B, Valeyre D, Wallaert B, Cadranel J, Dalphin J-C, et al. Diagnosis and management of idiopathic pulmonary fibrosis: French practical guidelines. Eur Respir Rev. 2014;23(132):193\u2013214.","journal-title":"Eur Respir Rev"},{"issue":"7","key":"1844_CR20","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.3390\/ijms17071189","volume":"17","author":"V Crincoli","year":"2016","unstructured":"Crincoli V, Fatone L, Fanelli M, Rotolo RP, Chial\u00e0 A, Favia G, et al. Orofacial manifestations and temporomandibular disorders of systemic scleroderma: an observational study. Int J Mol Sci. 2016;17(7):1189.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1844_CR21","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.oooo.2015.03.002","volume":"120","author":"M Dagenais","year":"2015","unstructured":"Dagenais M, MacDonald D, Baron M, Hudson M, Tatibouet S, Steele R, et al. The Canadian Systemic Sclerosis Oral Health Study IV: oral radiographic manifestations in systemic sclerosis compared with the general population. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;120(2):104\u201311.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"2","key":"1844_CR22","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/rheumatology\/kep093","volume":"49","author":"D Daoussis","year":"2010","unstructured":"Daoussis D, Liossis SN, Tsamandas AC, Kalogeropoulou C, Kazantzi A, Sirinian C, et al. Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study. Rheumatology (Oxford). 2010;49(2):271\u201380.","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"1844_CR23","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1111\/bjd.14412","volume":"175","author":"P Del Barrio-D\u00edaz","year":"2016","unstructured":"Del Barrio-D\u00edaz P, Moll-Manzur C, \u00c1lvarez-Veliz S, Vera-Kellet C. Topical sodium metabisulfite for the treatment of calcinosis cutis: a promising new therapy. Br J Dermatol. 2016;175(3):608\u201311.","journal-title":"Br J Dermatol"},{"issue":"1","key":"1844_CR24","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/bmt.2016.211","volume":"52","author":"N Del Papa","year":"2017","unstructured":"Del Papa N, Onida F, Zaccara E, Saporiti G, Maglione W, Tagliaferri E, et al. Autologous hematopoietic stem cell transplantation has better outcomes than conventional therapies in patients with rapidly progressive systemic sclerosis. Bone Marrow Transplant. 2017;52(1):53\u20138.","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"1844_CR25","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1097\/BOR.0b013e32834b8975","volume":"23","author":"CS Desai","year":"2011","unstructured":"Desai CS, Lee DC, Shah SJ. Systemic sclerosis and the heart: current diagnosis and management. Curr Opin Rheumatol. 2011;23(6):545\u201354.","journal-title":"Curr Opin Rheumatol"},{"issue":"26","key":"1844_CR26","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1056\/NEJMoa1903076","volume":"380","author":"O Distler","year":"2019","unstructured":"Distler O, Highland KB, Gahlemann M, Azuma A, Fischer A, Mayes MD, et al. Nintedanib for systemic sclerosis-associated interstitial lung disease. N Engl J Med. 2019;380(26):2518\u201328.","journal-title":"N Engl J Med"},{"issue":"1","key":"1844_CR27","doi-asserted-by":"publisher","first-page":"40","DOI":"10.4274\/Jcrpe.1166","volume":"6","author":"AV Ekbote","year":"2014","unstructured":"Ekbote AV, Danda S, Zankl A, Mandal K, Maguire T, Ungerer K. Patient with mutation in the matrix metalloproteinase 2 (MMP2) gene: a case report and review of the literature. J Clin Res Pediatr Endocrinol. 2014;6(1):40\u20136.","journal-title":"J Clin Res Pediatr Endocrinol"},{"issue":"5","key":"1844_CR28","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.semarthrit.2012.10.001","volume":"42","author":"H El Adssi","year":"2013","unstructured":"El Adssi H, Cirstea D, Virion J-M, Guillemin F, de Korwin J-D. Estimating the prevalence of systemic sclerosis in the Lorraine region, France, by the capture-recapture method. Semin Arthritis Rheum. 2013;42(5):530\u20138.","journal-title":"Semin Arthritis Rheum"},{"issue":"7","key":"1844_CR29","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1136\/annrheumdis-2012-202657","volume":"72","author":"M Elhai","year":"2013","unstructured":"Elhai M, Meunier M, Matucci-Cerinic M, Maurer B, Riemekasten G, Leturcq T, et al. Outcomes of patients with systemic sclerosis-associated polyarthritis and myopathy treated with tocilizumab or abatacept: a EUSTAR observational study. Ann Rheum Dis. 2013;72(7):1217\u201320.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"1844_CR30","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1136\/annrheumdis-2018-214816","volume":"78","author":"M Elhai","year":"2019","unstructured":"Elhai M, Boubaya M, Distler O, Smith V, Matucci-Cerinic M, Alegre Sancho JJ, et al. Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study. Ann Rheum Dis. 2019;78(7):979\u201387.","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"1844_CR31","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/nrgastro.2016.99","volume":"13","author":"A Emmanuel","year":"2016","unstructured":"Emmanuel A. Current management of the gastrointestinal complications of systemic sclerosis. Nat Rev Gastroenterol Hepatol. 2016;13(8):461\u201372.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1844_CR32","doi-asserted-by":"crossref","unstructured":"Farge D, Burt RK, Oliveira M-C, Mousseaux E, Rovira M, Marjanovic Z, et al. Cardiopulmonary assessment of patients with systemic sclerosis for hematopoietic stem cell transplantation: recommendations from the European Society for Blood and Marrow Transplantation Autoimmune Diseases Working Party and collaborating partners. Bone Marrow Transplant. 2017.","DOI":"10.1038\/bmt.2017.56"},{"issue":"6","key":"1844_CR33","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/j.1754-4505.2000.tb01157.x","volume":"20","author":"DJ Fischer","year":"2000","unstructured":"Fischer DJ, Patton LL. Scleroderma: oral manifestations and treatment challenges. Spec Care Dentist. 2000;20(6):240\u20134.","journal-title":"Spec Care Dentist"},{"key":"1844_CR34","doi-asserted-by":"crossref","unstructured":"Flaherty KR, Wells AU, Cottin V, Devaraj A, Walsh SLF, Inoue Y, et al. Nintedanib in Progressive Fibrosing Interstitial Lung Diseases. N Engl J Med. 2019. [Epub ahead of print]","DOI":"10.1056\/NEJMoa1908681"},{"issue":"3","key":"1844_CR35","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s11926-014-0491-y","volume":"17","author":"I Foeldvari","year":"2015","unstructured":"Foeldvari I. Update on juvenile systemic sclerosis. Curr Rheumatol Rep. 2015;17(3):18.","journal-title":"Curr Rheumatol Rep"},{"issue":"10","key":"1844_CR36","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1093\/rheumatology\/kes144","volume":"51","author":"I Foeldvari","year":"2012","unstructured":"Foeldvari I, Tyndall A, Zulian F, M\u00fcller-Ladner U, Czirjak L, Denton C, et al. Juvenile and young adult-onset systemic sclerosis share the same organ involvement in adulthood: data from the EUSTAR database. Rheumatol Oxf Engl. 2012;51(10):1832\u20137.","journal-title":"Rheumatol Oxf Engl"},{"issue":"2 Pt 2","key":"1844_CR37","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.lpm.2007.07.006","volume":"37","author":"C Franc\u00e8s","year":"2008","unstructured":"Franc\u00e8s C, Allanore Y, Cabane J, Carpentier P, Dumontier C, Hachulla E, et al. Management of digital ulcers from systemic scleroderma. Presse Med. 2008;37(2 Pt 2):271\u201385.","journal-title":"Presse Med"},{"issue":"2","key":"1844_CR38","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.recesp.2016.01.002","volume":"69","author":"N Gali\u00e8","year":"2016","unstructured":"Gali\u00e8 N, Humbert M, Vachiery J-L, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Rev Esp Cardiol (Engl Ed). 2016;69(2):177.","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"1","key":"1844_CR39","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10067-004-0942-3","volume":"24","author":"C Georges","year":"2005","unstructured":"Georges C, Chassany O, Mouthon L, Tiev K, Toledano C, Meyer O, et al. Validation of French version of the Scleroderma Health Assessment Questionnaire (SSc HAQ). Clin Rheumatol. 2005;24(1):3\u201310.","journal-title":"Clin Rheumatol"},{"key":"1844_CR40","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1093\/rheumatology\/kel189","volume":"45","author":"C Georges","year":"2006","unstructured":"Georges C, Chassany O, Toledano C, Mouthon L, Tiev K, Meyer O, et al. Impact of pain in health related quality of life of patients with systemic sclerosis. Rheumatology (Oxford). 2006;45:1298\u2013302.","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"1844_CR41","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.autrev.2015.07.008","volume":"14","author":"D Giuggioli","year":"2015","unstructured":"Giuggioli D, Lumetti F, Colaci M, Fallahi P, Antonelli A, Ferri C. Rituximab in the treatment of patients with systemic sclerosis. Our experience and review of the literature. Autoimmun Rev. 2015;14(11):1072\u20138.","journal-title":"Autoimmun Rev"},{"issue":"5","key":"1844_CR42","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/annrheumdis-2015-208840","volume":"75","author":"C G\u00f6testam Skorpen","year":"2016","unstructured":"G\u00f6testam Skorpen C, Hoeltzenbein M, Tincani A, Fischer-Betz R, Elefant E, Chambers C, et al. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis. 2016;75(5):795\u2013810.","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"1844_CR43","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1136\/annrheumdis-2014-205681","volume":"74","author":"B Granel","year":"2015","unstructured":"Granel B, Daumas A, Jouve E, Harl\u00e9 J-R, Nguyen P-S, Chabannon C, et al. Safety, tolerability and potential efficacy of injection of autologous adipose-derived stromal vascular fraction in the fingers of patients with systemic sclerosis: an open-label phase I trial. Ann Rheum Dis. 2015;74(12):2175\u201382.","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"1844_CR44","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1136\/ard.2008.095836","volume":"68","author":"A-L Hachulla","year":"2009","unstructured":"Hachulla A-L, Launay D, Gaxotte V, de Groote P, Lamblin N, Devos P, et al. Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients. Ann Rheum Dis. 2009;68(12):1878\u201384.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"1844_CR45","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1002\/art.24525","volume":"60","author":"E Hachulla","year":"2009","unstructured":"Hachulla E, de Groote P, Gressin V, Sibilia J, Diot E, Carpentier P, et al. The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France. Arthritis Rheum. 2009;60(6):1831\u20139.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"1844_CR46","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/acr.20070","volume":"62","author":"AL Herrick","year":"2010","unstructured":"Herrick AL, Ennis H, Bhushan M, Silman AJ, Baildam EM. Incidence of childhood linear scleroderma and systemic sclerosis in the UK and Ireland. Arthritis Care Res (Hoboken). 2010;62(2):213\u20138.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"12","key":"1844_CR47","doi-asserted-by":"publisher","first-page":"3962","DOI":"10.1002\/art.22204","volume":"54","author":"RK Hoyles","year":"2006","unstructured":"Hoyles RK, Ellis RW, Wellsbury J, Lees B, Newlands P, Goh NSL, et al. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma. Arthritis Rheum. 2006;54(12):3962\u201370.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"1844_CR48","doi-asserted-by":"publisher","first-page":"R30","DOI":"10.1186\/ar2634","volume":"11","author":"N Hunzelmann","year":"2009","unstructured":"Hunzelmann N, Moinzadeh P, Genth E, Krieg T, Lehmacher W, Melchers I, et al. High frequency of corticosteroid and immunosuppressive therapy in patients with systemic sclerosis despite limited evidence for efficacy. Arthritis Res Ther. 2009;11(2):R30.","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"1844_CR49","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.gtc.2011.09.010","volume":"40","author":"F Joly","year":"2011","unstructured":"Joly F, Amiot A, Messing B. Nutritional support in the severely compromised motility patient: when and how? Gastroenterol Clin N Am. 2011;40(4):845\u201351.","journal-title":"Gastroenterol Clin N Am"},{"issue":"6","key":"1844_CR50","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1136\/annrheumdis-2013-204522","volume":"74","author":"S Jordan","year":"2015","unstructured":"Jordan S, Distler JHW, Maurer B, Huscher D, van Laar JM, Allanore Y, et al. Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group. Ann Rheum Dis. 2015;74(6):1188\u201394.","journal-title":"Ann Rheum Dis"},{"issue":"10038","key":"1844_CR51","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1016\/S0140-6736(16)00232-4","volume":"387","author":"D Khanna","year":"2016","unstructured":"Khanna D, Denton CP, Jahreis A, van Laar JM, Frech TM, Anderson ME, et al. Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial. Lancet. 2016;387(10038):2630\u201340.","journal-title":"Lancet"},{"key":"1844_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/art.41055","author":"D Khanna","year":"2019","unstructured":"Khanna D, Spino C, Johnson S, Chung L, Whitfield M, Denton CP, et al. Abatacept in early diffuse cutaneous systemic sclerosis: results of a phase 2 investigator-initiated, multicenter, double-blind randomized placebo-controlled trial. Arthritis Rheumatol. 2019. https:\/\/doi.org\/10.1002\/art.41055.","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"1844_CR53","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1093\/rheumatology\/kew499","volume":"56","author":"O Kowal-Bielecka","year":"2017","unstructured":"Kowal-Bielecka O, Chwiesko-Minarowska S, Bernatowicz PL, Allanore Y, Radstake T, Matucci-Cerinic M, et al. The arachidonate 5-lipoxygenase activating protein gene polymorphism is associated with the risk of scleroderma-related interstitial lung disease: a multicentre European Scleroderma Trials and Research group (EUSTAR) study. Rheumatology (Oxford). 2017;56(5):844\u201352.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"1844_CR54","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1378\/chest.13-0587","volume":"145","author":"SE Lapinsky","year":"2014","unstructured":"Lapinsky SE, Tram C, Mehta S, Maxwell CV. Restrictive lung disease in pregnancy. Chest. 2014;145(2):394\u20138.","journal-title":"Chest"},{"issue":"10 Pt 2","key":"1844_CR55","doi-asserted-by":"publisher","first-page":"e345","DOI":"10.1016\/j.lpm.2014.01.020","volume":"43","author":"D Launay","year":"2014","unstructured":"Launay D, Savale L, Berezne A, Le Pavec J, Hachulla E, Mouthon L, et al. Lung and heart-lung transplantation for systemic sclerosis patients. A monocentric experience of 13 patients, review of the literature and position paper of a multidisciplinary Working Group. Presse Med. 2014;43(10 Pt 2):e345-363.","journal-title":"Presse Med"},{"issue":"5","key":"1844_CR56","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3899\/jrheum.160817","volume":"44","author":"M-G Lazzaroni","year":"2017","unstructured":"Lazzaroni M-G, Cavazzana I, Colombo E, Dobrota R, Hernandez J, Hesselstrand R, et al. Malignancies in patients with Anti-RNA polymerase III antibodies and systemic sclerosis: analysis of the EULAR scleroderma trials and research cohort and possible recommendations for screening. J Rheumatol. 2017;44(5):639\u201347.","journal-title":"J Rheumatol"},{"issue":"2","key":"1844_CR57","first-page":"16","volume":"56","author":"DM Leader","year":"2007","unstructured":"Leader DM. Scleroderma and dentistry: every dentist is a scleroderma specialist. J Mass Dent Soc. 2007;56(2):16\u20139.","journal-title":"J Mass Dent Soc"},{"issue":"2","key":"1844_CR58","first-page":"202","volume":"15","author":"EC LeRoy","year":"1988","unstructured":"LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988;15(2):202\u20135.","journal-title":"J Rheumatol"},{"issue":"7","key":"1844_CR59","first-page":"1573","volume":"28","author":"EC LeRoy","year":"2001","unstructured":"LeRoy EC, Medsger TA. Criteria for the classification of early systemic sclerosis. J Rheumatol. 2001;28(7):1573\u20136.","journal-title":"J Rheumatol"},{"key":"1844_CR60","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.annder.2011.06.011","volume":"138","author":"C Lok","year":"2011","unstructured":"Lok C, Mouthon L, S\u00e9gard M, Richard MA, Guillevin L. Les ulc\u00e8res digitaux de la scl\u00e9rodemrie syst\u00e9mique. Ann Dermatol Venereol. 2011;138:762\u20138.","journal-title":"Ann Dermatol Venereol"},{"issue":"7","key":"1844_CR61","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s00296-010-1382-9","volume":"31","author":"S Maddali-Bongi","year":"2011","unstructured":"Maddali-Bongi S, Landi G, Galluccio F, Del Rosso A, Miniati I, Conforti ML, et al. The rehabilitation of facial involvement in systemic sclerosis: efficacy of the combination of connective tissue massage, Kabat\u2019s technique and kinesitherapy: a randomized controlled trial. Rheumatol Int. 2011;31(7):895\u2013901.","journal-title":"Rheumatol Int"},{"issue":"2","key":"1844_CR62","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/rheumatology\/ken388","volume":"48","author":"G Martini","year":"2009","unstructured":"Martini G, Vittadello F, Kasap\u00e7opur O, Magni Manzoni S, Corona F, Duarte-Salazar C, et al. Factors affecting survival in juvenile systemic sclerosis. Rheumatol Oxf Engl. 2009;48(2):119\u201322.","journal-title":"Rheumatol Oxf Engl"},{"issue":"1","key":"1844_CR63","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.acvd.2009.06.009","volume":"103","author":"C Meune","year":"2010","unstructured":"Meune C, Vignaux O, Kahan A, Allanore Y. Heart involvement in systemic sclerosis: evolving concept and diagnostic methodologies. Arch Cardiovasc Dis. 2010;103(1):46\u201352.","journal-title":"Arch Cardiovasc Dis"},{"key":"1844_CR64","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1111\/j.1600-6143.2005.01035.x","volume":"5","author":"P-TT Pham","year":"2005","unstructured":"Pham P-TT, Pham P-CT, Danovitch GM, Gritsch HA, Singer J, Wallace WD, Hayashi R, Wilkinson AH. Predictors and risk factors for recurrent scleroderma renal crisis in the Kidney Allograft: case report and review of the literature. Am J Transplant. 2005;5:2565\u20139.","journal-title":"Am J Transplant"},{"issue":"7","key":"1844_CR65","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1902\/jop.2016.150475","volume":"87","author":"N Pischon","year":"2016","unstructured":"Pischon N, Hoedke D, Kurth S, Lee P, Dommisch H, Steinbrecher A, et al. Increased periodontal attachment loss in patients with systemic sclerosis. J Periodontol. 2016;87(7):763\u201371.","journal-title":"J Periodontol"},{"issue":"12","key":"1844_CR66","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1136\/annrheumdis-2015-208213","volume":"75","author":"M Ponsoye","year":"2016","unstructured":"Ponsoye M, Frantz C, Ruzehaji N, Nicco C, Elhai M, Ruiz B, et al. Treatment with abatacept prevents experimental dermal fibrosis and induces regression of established inflammation-driven fibrosis. Ann Rheum Dis. 2016;75(12):2142\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"1844_CR67","doi-asserted-by":"publisher","first-page":"517","DOI":"10.2165\/00003495-200767040-00003","volume":"67","author":"JE Pope","year":"2007","unstructured":"Pope JE. The diagnosis and treatment of Raynaud\u2019s phenomenon: a practical approach. Drugs. 2007;67(4):517\u201325.","journal-title":"Drugs"},{"issue":"6","key":"1844_CR68","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1002\/1529-0131(200106)44:6<1351::AID-ART227>3.0.CO;2-I","volume":"44","author":"JE Pope","year":"2001","unstructured":"Pope JE, Bellamy N, Seibold JR, Baron M, Ellman M, Carette S, et al. A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma. Arthritis Rheum. 2001;44(6):1351\u20138.","journal-title":"Arthritis Rheum"},{"key":"1844_CR69","doi-asserted-by":"crossref","unstructured":"Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum. 1980;23(5):581\u201390.","DOI":"10.1002\/art.1780230510"},{"issue":"7","key":"1844_CR70","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1002\/acr.23098","volume":"69","author":"F Rannou","year":"2017","unstructured":"Rannou F, Boutron I, Mouthon L, Sanchez K, Tiffreau V, Hachulla E, et al. Personalized physical therapy versus usual care for patients with systemic sclerosis: a randomized controlled trial. Arthritis Care Res (Hoboken). 2017;69(7):1050\u20139.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"1844_CR71","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/art.22468","volume":"57","author":"F Rannou","year":"2007","unstructured":"Rannou F, Poiraudeau S, Berezn\u00e9 A, Baubet T, Le-Guern V, Cabane J, et al. Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin Hand Function Scale, Health Assessment Questionnaire (HAQ), Systemic Sclerosis HAQ, and Medical Outcomes Study 36-Item Short Form Health Survey. Arthritis Rheum. 2007;57(1):94\u2013102.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"1844_CR72","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.autrev.2017.02.008","volume":"16","author":"S Sanges","year":"2017","unstructured":"Sanges S, Rivi\u00e8re S, Mekinian A, Martin T, Le Quellec A, Chatelus E, et al. Intravenous immunoglobulins in systemic sclerosis: data from a French nationwide cohort of 46 patients and review of the literature. Autoimmun Rev. 2017;16(4):377\u201384.","journal-title":"Autoimmun Rev"},{"issue":"6","key":"1844_CR73","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1002\/acr.20448","volume":"63","author":"AA Schouffoer","year":"2011","unstructured":"Schouffoer AA, Ninaber MK, Beaart-van de Voorde LJJ, van der Giesen FJ, de Jong Z, Stolk J, et al. Randomized comparison of a multidisciplinary team care program with usual care in patients with systemic sclerosis. Arthritis Care Res (Hoboken). 2011;63(6):909\u201317.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"8","key":"1844_CR74","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1111\/apt.12479","volume":"38","author":"SC Shah","year":"2013","unstructured":"Shah SC, Day LW, Somsouk M, Sewell JL. Meta-analysis: antibiotic therapy for small intestinal bacterial overgrowth. Aliment Pharmacol Ther. 2013;38(8):925\u201334.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"1844_CR75","doi-asserted-by":"publisher","first-page":"1801913","DOI":"10.1183\/13993003.01913-2018","volume":"53","author":"G Simonneau","year":"2019","unstructured":"Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 2019;53(1):1801913.","journal-title":"Eur Respir J"},{"issue":"11","key":"1844_CR76","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1080\/1744666X.2016.1194201","volume":"12","author":"V Sobanski","year":"2016","unstructured":"Sobanski V, Launay D, Depret S, Ducloy-Bouthors A-S, Hachulla E. Special considerations in pregnant systemic sclerosis patients. Expert Rev Clin Immunol. 2016;12(11):1161\u201373.","journal-title":"Expert Rev Clin Immunol"},{"issue":"2","key":"1844_CR77","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0889-857X(03)00016-4","volume":"29","author":"VD Steen","year":"2003","unstructured":"Steen VD. Scleroderma renal crisis. Rheum Dis Clin N Am. 2003;29(2):315\u201333.","journal-title":"Rheum Dis Clin N Am"},{"key":"1844_CR78","doi-asserted-by":"publisher","first-page":"600","DOI":"10.7326\/0003-4819-133-8-200010170-00010","volume":"133","author":"VD Steen","year":"2000","unstructured":"Steen VD, Medsger TA. Long-term outcomes of scleroderma renal crisis. Ann Intern Med. 2000;133:600\u20133.","journal-title":"Ann Intern Med"},{"issue":"6","key":"1844_CR79","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1097\/MOG.0000000000000220","volume":"31","author":"J Tack","year":"2015","unstructured":"Tack J, Carbone F, Rotondo A. Gastroparesis. Curr Opin Gastroenterol. 2015;31(6):499\u2013505.","journal-title":"Curr Opin Gastroenterol"},{"issue":"6","key":"1844_CR80","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1002\/art.34350","volume":"64","author":"M Taraborelli","year":"2012","unstructured":"Taraborelli M, Ramoni V, Brucato A, Air\u00f2 P, Bajocchi G, Bellisai F, et al. Brief report: successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: an Italian multicenter study. Arthritis Rheum. 2012;64(6):1970\u20137.","journal-title":"Arthritis Rheum"},{"issue":"10","key":"1844_CR81","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1164\/rccm.200702-326OC","volume":"176","author":"DP Tashkin","year":"2007","unstructured":"Tashkin DP, Elashoff R, Clements PJ, Roth MD, Furst DE, Silver RM, et al. Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease. Am J Respir Crit Care Med. 2007;176(10):1026\u201334.","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"1844_CR82","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/S2213-2600(16)30152-7","volume":"4","author":"DP Tashkin","year":"2016","unstructured":"Tashkin DP, Roth MD, Clements PJ, Furst DE, Khanna D, Kleerup EC, et al. Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial. Lancet Respir Med. 2016;4(9):708\u201319.","journal-title":"Lancet Respir Med"},{"key":"1844_CR83","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1136\/ard.2006.066985","volume":"67","author":"L Teixeira","year":"2008","unstructured":"Teixeira L, Mouthon L, Mahr A, Berezn\u00e9 A, Agard C, Mehrenberger M, No\u00ebl L-H, Trolliet P, Frances C, Cabane J, Guillevin L, Group Fran\u00e7ais de Recherche sur le Scl\u00e9rodermie GFRS. Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients. Ann Rheum Dis. 2008;67:110\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"1844_CR84","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.autrev.2017.12.010","volume":"17","author":"M Thiebaut","year":"2018","unstructured":"Thiebaut M, Launay D, Rivi\u00e8re S, Mah\u00e9vas T, Bellakhal S, Hachulla E, et al. Efficacy and safety of rituximab in systemic sclerosis: French retrospective study and literature review. Autoimmun Rev. 2018;17(6):582\u20137.","journal-title":"Autoimmun Rev"},{"issue":"2","key":"1844_CR85","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1093\/rheumatology\/keh390","volume":"44","author":"AE Thompson","year":"2005","unstructured":"Thompson AE, Pope JE. Calcium channel blockers for primary Raynaud\u2019s phenomenon: a meta-analysis. Rheumatology (Oxford). 2005;44(2):145\u201350.","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"1844_CR86","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1111\/j.1440-1754.2012.02435.x","volume":"48","author":"S Trainito","year":"2012","unstructured":"Trainito S, Favero L, Martini G, Pedersen TK, Favero V, Herlin T, et al. Odontostomatologic involvement in juvenile localised scleroderma of the face. J Paediatr Child Health. 2012;48(7):572\u20136.","journal-title":"J Paediatr Child Health"},{"key":"1844_CR87","doi-asserted-by":"crossref","unstructured":"Vandecasteele E, Drieghe B, Melsens K, Thevissen K, De Pauw M, Deschepper E, et al. Screening for pulmonary arterial hypertension in an unselected prospective systemic sclerosis cohort. Eur Respir J. 2017;49(5).","DOI":"10.1183\/13993003.02275-2016"},{"issue":"11","key":"1844_CR88","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative. Arthritis Rheum. 2013;65(11):2737\u201347.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"1844_CR89","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1093\/rheumatology\/35.4.364","volume":"35","author":"FH van den Hoogen","year":"1996","unstructured":"van den Hoogen FH, Boerbooms AM, Swaak AJ, Rasker JJ, van Lier HJ, van de Putte LB. Comparison of methotrexate with placebo in the treatment of systemic sclerosis: a 24 week randomized double-blind trial, followed by a 24 week observational trial. Br J Rheumatol. 1996;35(4):364\u201372.","journal-title":"Br J Rheumatol"},{"issue":"1","key":"1844_CR90","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.revmed.2008.06.012","volume":"30","author":"C Vincent","year":"2009","unstructured":"Vincent C, Agard C, Barbarot S, N\u2019Guyen J-M, Planchon B, Durant C, et al. Orofacial manifestations of systemic sclerosis: a study of 30 consecutive patients. Rev Med Interne. 2009;30(1):5\u201311.","journal-title":"Rev Med Interne"},{"key":"1844_CR91","doi-asserted-by":"crossref","unstructured":"Walker KM, Pope J, participating members of the Scleroderma Clinical Trials Consortium (SCTC), Canadian Scleroderma Research Group (CSRG). Treatment of systemic sclerosis complications: what to use when first-line treatment fails\u2014a consensus of systemic sclerosis experts. Semin Arthritis Rheum. 2012;42(1):42\u201355.","DOI":"10.1016\/j.semarthrit.2012.01.003"},{"issue":"10","key":"1844_CR92","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1002\/acr.22595","volume":"67","author":"LM Willems","year":"2015","unstructured":"Willems LM, Vriezekolk JE, Schouffoer AA, Poole JL, Stamm TA, Bostr\u00f6m C, et al. Effectiveness of nonpharmacologic interventions in systemic sclerosis: a systematic review. Arthritis Care Res (Hoboken). 2015;67(10):1426\u201339.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"1844_CR93","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3109\/09638288.2011.587589","volume":"34","author":"HK Yuen","year":"2012","unstructured":"Yuen HK, Marlow NM, Reed SG, Mahoney S, Summerlin LM, Leite R, et al. Effect of orofacial exercises on oral aperture in adults with systemic sclerosis. Disabil Rehabil. 2012;34(1):84\u20139.","journal-title":"Disabil Rehabil"},{"issue":"2 Suppl 65","key":"1844_CR94","first-page":"S26","volume":"29","author":"HK Yuen","year":"2011","unstructured":"Yuen HK, Weng Y, Bandyopadhyay D, Reed SG, Leite RS, Silver RM. Effect of a multi-faceted intervention on gingival health among adults with systemic sclerosis. Clin Exp Rheumatol. 2011;29(2 Suppl 65):S26-32.","journal-title":"Clin Exp Rheumatol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-01844-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-021-01844-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-01844-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,25]],"date-time":"2021-07-25T21:02:41Z","timestamp":1627246961000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-021-01844-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":94,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["1844"],"URL":"https:\/\/doi.org\/10.1186\/s13023-021-01844-y","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"26 April 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"EH reports consulting fees\/meeting fees from Actelion, Boehringer Ingelheim, Bayer, GSK, Roche-Chugai, Sanofi-Genzyme; speaking fees from Actelion, GSK, Roche-Chugai; and research funding from Octapharma, CSL Behring, GSK, Roche-Chugai and Actelion. CA reports no conflicts of interest. YA reports consulting fees\/meeting fees from Actelion, Sanofi; Boehringer, Inventiva, Roche, Bayer, Sandoz, Medac, BMS; and research funding from Pfizer, BMS, Sandoz, Roche, Inventiva and Sanofi. JA reports no conflicts of interest. BBM reports no conflicts of interest. ABELOT reports no conflicts of interest. ABEREZNE reports no conflicts of interest. ASB reports no conflicts of interest. GW reports no conflicts of interest. JC reports no conflicts of interest. PDG reports consulting fees\/meeting fees from Actelion, Bayer, MSD; speaking fees from Actelion, BAYER. ED reports consulting fees\/meeting fees from Actelion. FD reports no conflicts of interest. PJ reports no conflicts of interest. FJ reports no conflicts of interest. DL reports no conflicts of interest. VL reports consulting fees\/meeting fees from GSK and Astra-Zeneca. JSL reports no conflicts of interest. GL reports no conflicts of interest. CM reports no conflicts of interest. BM reports no conflicts of interest. CN reports no conflicts of interest. NO reports no conflicts of interest. FP reports no conflicts of interest. MAR reports no conflicts of interest. JR reports no conflicts of interest. AR reports no conflicts of interest. OS reports no conflicts of interest. VS reports no conflicts of interest. MET reports consulting fees\/meeting fees from UCB, Lilly, Abbvie, MSD, Pfizer, Medac, Roche, Novartis, and BMS. LM reports no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"322"}}